EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Endovascular Treatment for Transplant Renal Artery Stenosis: 10 Years’ Experience from a Single Center

Xibin Pu, Bing Wang, Jun Pan, Xinyu Yu, Wei Dai, Yangyan He

Kidney and Blood Pressure Research · 2024

DOI: 10.1159/000541125 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Kidney and Blood Pressure Research, 2024. Verfasst von Xibin Pu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Haiyan People's Hospital, Hangzhou, China. Hauptthemen laut MEDLINE: Renal Artery Obstruction, Kidney Transplantation, Endovascular Procedures. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Transplant renal artery stenosis (TRAS) is a common post-renal transplant complication. Although endovascular treatment is widely used to treat TRAS, previous research has been limited by small sample sizes. This article aimed to present the clinical outcomes of endovascular treatment for TRAS in a large sample.

Methods

Between January 2010 and December 2019, this study included patients with TRAS who were admitted to our center. All patients’ clinical symptoms, comorbidities, imaging data, treatment, and follow-up results were reviewed retrospectively.

Results

Seventy two patients participated in this study. The median time between renal transplantation and TRAS was 5.25 months. Out of 72 patients, 55 (76.4%) received balloon dilatation in conjunction with stent deployment, 10 (13.9%) received drug-coated balloon dilatation alone, and 7 (9.7%) received balloon dilatation alone. The median follow-up period was 27 months. Primary patency rates were 100%, 81.8%, 74.5%, 64.6%, and 61.8% at 1, 3, 6, 12, and 24 months. A total of 23 patients were found to have restenosis during follow-up, with 6 (26.1%) requiring reintervention and none remaining restenosis after the second treatment. In the subgroup analysis of the three types of stenosis, patients with transplant renal stenosis at the anastomosis had a significantly higher rate of primary patency. Between endovascular treatments, the primary patency rate, postoperative creatinine clearance, and mean systolic blood pressure did not differ significantly.

Conclusion

Endovascular treatment resulted in favorable short-term patency as well as effective relief of renal dysfunction and renal hypertension in TRAS patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Renal Artery ObstructionKidney TransplantationEndovascular ProceduresHumansMaleFemaleMiddle AgedRetrospective StudiesAdultStentsTreatment OutcomeAged

Stichwörter der Autor:innen

Endovascular treatmentPrimary patencyReinterventionTransplanted renal artery stenosis

Autor:innen und Institutionen

  • Department of General Surgery, Haiyan People's Hospital, Hangzhou, China.
  • Department of Vascular Surgery, The First Affiliated Hospital of Zhejiang University, Hangzhou, China.

Zitieren

APA

Pu, X., Wang, B., Pan, J., Yu, X., Dai, W., & He, Y. (2024). Endovascular Treatment for Transplant Renal Artery Stenosis: 10 Years’ Experience from a Single Center. Kidney and Blood Pressure Research. https://doi.org/10.1159/000541125

Vancouver

Pu X, Wang B, Pan J, Yu X, Dai W, He Y. Endovascular Treatment for Transplant Renal Artery Stenosis: 10 Years’ Experience from a Single Center. Kidney and Blood Pressure Research. 2024. doi:10.1159/000541125

BibTeX
@article{Pu2024,
  author = {Pu, Xibin and Wang, Bing and Pan, Jun and Yu, Xinyu and Dai, Wei and He, Yangyan},
  title = {Endovascular Treatment for Transplant Renal Artery Stenosis: 10 Years’ Experience from a Single Center},
  journal = {Kidney and Blood Pressure Research},
  year = {2024},
  doi = {10.1159/000541125}
}
Kostenlos starten →